Energetics and metabolism in the failing heart: Important but poorly understood

Aslan T. Turer, Craig R. Malloy, Christopher B. Newgard, Mihai V. Podgoreanu

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Purpose of review: Profound abnormalities in myocardial energy metabolism occur in heart failure and correlate with clinical symptoms and survival. Available comprehensive human metabolic data come from small studies, enrolling patients across heart failure causes, at different disease stages, and using different methodologies, and is often contradictory. Remaining fundamental gaps in knowledge include whether observed shifts in cardiac substrate utilization are adaptive or maladaptive, causal or an epiphenomenon of heart failure. Recent findings: Recent studies have characterized the temporal changes in myocardial substrate metabolism involved in progression of heart failure, the role of insulin resistance, and the mechanisms of mitochondrial dysfunction in heart failure. The concept of metabolic inflexibility has been proposed to explain the lack of energetic and mechanical reserve in the failing heart. Summary: Despite current therapies, which provide substantial benefits to patients, heart failure remains a progressive disease, and new approaches to treatment are necessary. Developing metabolic interventions would be facilitated by systems-level integration of current knowledge on myocardial metabolic control. Although preliminary evidence suggests that metabolic modulators inducing a shift towards carbohydrate utilization seem generally beneficial in the failing heart, such interventions should be matched to the stage of metabolic deregulation in the progression of heart failure.

Original languageEnglish (US)
Pages (from-to)458-465
Number of pages8
JournalCurrent Opinion in Clinical Nutrition and Metabolic Care
Volume13
Issue number4
DOIs
StatePublished - Jul 2010

Fingerprint

Heart Failure
Systems Integration
Energy Metabolism
Insulin Resistance
Carbohydrates
Survival
Therapeutics

Keywords

  • glucose metabolism
  • heart failure
  • myocardial energetics

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Energetics and metabolism in the failing heart : Important but poorly understood. / Turer, Aslan T.; Malloy, Craig R.; Newgard, Christopher B.; Podgoreanu, Mihai V.

In: Current Opinion in Clinical Nutrition and Metabolic Care, Vol. 13, No. 4, 07.2010, p. 458-465.

Research output: Contribution to journalArticle

@article{37c8279bdb4a45569606728c1c7077a0,
title = "Energetics and metabolism in the failing heart: Important but poorly understood",
abstract = "Purpose of review: Profound abnormalities in myocardial energy metabolism occur in heart failure and correlate with clinical symptoms and survival. Available comprehensive human metabolic data come from small studies, enrolling patients across heart failure causes, at different disease stages, and using different methodologies, and is often contradictory. Remaining fundamental gaps in knowledge include whether observed shifts in cardiac substrate utilization are adaptive or maladaptive, causal or an epiphenomenon of heart failure. Recent findings: Recent studies have characterized the temporal changes in myocardial substrate metabolism involved in progression of heart failure, the role of insulin resistance, and the mechanisms of mitochondrial dysfunction in heart failure. The concept of metabolic inflexibility has been proposed to explain the lack of energetic and mechanical reserve in the failing heart. Summary: Despite current therapies, which provide substantial benefits to patients, heart failure remains a progressive disease, and new approaches to treatment are necessary. Developing metabolic interventions would be facilitated by systems-level integration of current knowledge on myocardial metabolic control. Although preliminary evidence suggests that metabolic modulators inducing a shift towards carbohydrate utilization seem generally beneficial in the failing heart, such interventions should be matched to the stage of metabolic deregulation in the progression of heart failure.",
keywords = "glucose metabolism, heart failure, myocardial energetics",
author = "Turer, {Aslan T.} and Malloy, {Craig R.} and Newgard, {Christopher B.} and Podgoreanu, {Mihai V.}",
year = "2010",
month = "7",
doi = "10.1097/MCO.0b013e32833a55a5",
language = "English (US)",
volume = "13",
pages = "458--465",
journal = "Current Opinion in Clinical Nutrition and Metabolic Care",
issn = "1363-1950",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Energetics and metabolism in the failing heart

T2 - Important but poorly understood

AU - Turer, Aslan T.

AU - Malloy, Craig R.

AU - Newgard, Christopher B.

AU - Podgoreanu, Mihai V.

PY - 2010/7

Y1 - 2010/7

N2 - Purpose of review: Profound abnormalities in myocardial energy metabolism occur in heart failure and correlate with clinical symptoms and survival. Available comprehensive human metabolic data come from small studies, enrolling patients across heart failure causes, at different disease stages, and using different methodologies, and is often contradictory. Remaining fundamental gaps in knowledge include whether observed shifts in cardiac substrate utilization are adaptive or maladaptive, causal or an epiphenomenon of heart failure. Recent findings: Recent studies have characterized the temporal changes in myocardial substrate metabolism involved in progression of heart failure, the role of insulin resistance, and the mechanisms of mitochondrial dysfunction in heart failure. The concept of metabolic inflexibility has been proposed to explain the lack of energetic and mechanical reserve in the failing heart. Summary: Despite current therapies, which provide substantial benefits to patients, heart failure remains a progressive disease, and new approaches to treatment are necessary. Developing metabolic interventions would be facilitated by systems-level integration of current knowledge on myocardial metabolic control. Although preliminary evidence suggests that metabolic modulators inducing a shift towards carbohydrate utilization seem generally beneficial in the failing heart, such interventions should be matched to the stage of metabolic deregulation in the progression of heart failure.

AB - Purpose of review: Profound abnormalities in myocardial energy metabolism occur in heart failure and correlate with clinical symptoms and survival. Available comprehensive human metabolic data come from small studies, enrolling patients across heart failure causes, at different disease stages, and using different methodologies, and is often contradictory. Remaining fundamental gaps in knowledge include whether observed shifts in cardiac substrate utilization are adaptive or maladaptive, causal or an epiphenomenon of heart failure. Recent findings: Recent studies have characterized the temporal changes in myocardial substrate metabolism involved in progression of heart failure, the role of insulin resistance, and the mechanisms of mitochondrial dysfunction in heart failure. The concept of metabolic inflexibility has been proposed to explain the lack of energetic and mechanical reserve in the failing heart. Summary: Despite current therapies, which provide substantial benefits to patients, heart failure remains a progressive disease, and new approaches to treatment are necessary. Developing metabolic interventions would be facilitated by systems-level integration of current knowledge on myocardial metabolic control. Although preliminary evidence suggests that metabolic modulators inducing a shift towards carbohydrate utilization seem generally beneficial in the failing heart, such interventions should be matched to the stage of metabolic deregulation in the progression of heart failure.

KW - glucose metabolism

KW - heart failure

KW - myocardial energetics

UR - http://www.scopus.com/inward/record.url?scp=77954348958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954348958&partnerID=8YFLogxK

U2 - 10.1097/MCO.0b013e32833a55a5

DO - 10.1097/MCO.0b013e32833a55a5

M3 - Article

C2 - 20453645

AN - SCOPUS:77954348958

VL - 13

SP - 458

EP - 465

JO - Current Opinion in Clinical Nutrition and Metabolic Care

JF - Current Opinion in Clinical Nutrition and Metabolic Care

SN - 1363-1950

IS - 4

ER -